2nd Quarter - Report
BALLARD PARTNERS for FERRING PHARMACEUTICALS, INC.
Firm
Income
$110,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Tariff (miscellaneous tariff bills) TAR
Advocacy regarding IVF access and tariffs.
Foreign entity interest: Ferring Holding SA, as a parent company of Ferring Pharmaceuticals, Inc., identified on the LD-1 report, has indirect interest in the issues identified in this report.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALISON ANWAY | LA to Senator Pat Roberts 2006-2010 |
| BRIAN BALLARD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.